Olga Vedrova

HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?

Y. Andreeva, V. Strelnikov, S. Khokhlova, 2023, International journal of molecular sciences.

Abstract 1241: Profile of BRCA1/BRCA2 mutations in Russian ovarian cancer population detected by NGS and MLPA analysis: Interim results of OVATAR study

E. Imyanitov, S. Tjulandin, I. Demidova, 2018, Epidemiology.

Non-interventional study OVATAR final report: Diagnostic and treatment approaches in Russian ovarian cancer population—BRCAm group analysis.

S. Tjulandin, V. Gorbunova, A. Lisyanskaya, 2019, Journal of Clinical Oncology.